Back to search
FDAFDA · Food and drugs·Recall number D-0334-2020

Viatrexx-Infla, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0279, NDC 73069-249-41.

Published November 20, 2019 · Recall initiated: October 15, 2019

Summary

FDA records drug Class II recall D-0334-2020, published November 20, 2019 and initiated October 15, 2019. Recalling firm: 8046255 Canada Inc. DBA Viatrexx; Status: Terminated; Reported quantity: 54 vials; Lot: Lot Numbers: 19-S00012, Exp. May: 2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
8046255 Canada Inc. DBA Viatrexx
Distributor
Distributed to physicians Nationwide throughout the United States and Puerto Rico.
Lot
Lot Numbers: 19-S00012, Exp. May: 2020
Risk classification
Class II
Area (FDA)
drug
Country
Canada

Related recalls

Questions about this recall

Was Viatrexx-Infla, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0279, NDC 73069-249-41. recalled?

Yes. FDA published recall D-0334-2020 on November 20, 2019. Reported hazard: Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release